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Abstract-The effect of dietary ascorbate on hepatic UDP giucuronyitransferase (UDPGT) appears to 
be selective in that only certain isozymes of UDPGT are jeopardized. In this study, ascorbic acid 
deficiency produced a 68% reduction in the specific activity of hepatic UDPGT towards ~-nitrophenoi. 
Earlier studies showed a reduction in UDPGT activity towards p-aminophenol in ascorbate-deficient 
guinea pigs, whereas bilirubin and acetaminophen giucuronidation were unaffected. Kinetic studies 
suggest that p-aminophenol and p-nitrophenoi arc metabolized by a single isozyme in that p-nitrophenol 
was found to be a competitive inhibitor of p-aminophenol glucuronidation. Both qualitative and 
quantitative studies on partially purified UDPGT from ascorbate-deficient and ascorbate-supplemented 
guinea pigs were carried out to investigate the biochemical role of the vitamin. Qualitative differences 
were observed in UDPGT from ascorbate-de~cient animals and included an increased lability to: thermal 
inactivation; storage at 4”; and purification with UDP-glucuronic acid agarose column chromatography. 
Furthermore, an analysis of the microsomai membrane showed a 14% increase in membrane Ruidity in 
ascorbate deficiency. Ascorbic acid added in vitro could not reverse the increase in fluidity observed in 
ascorbate-deficient microsomai membranes; however, ascorbyipaimitate, a more iipophiiic form of the 
vitamin, was effective. Paimitic acid had no effect on membrane fluidity in microsomes from either the 
ascorbate-supplemented or ascorbate-deficient animals. This increase in membrane fluidity could not 
be explained by differences in cholesteroi, total phosphoiipid, or phosphatidyichoiine content of hepatic 
microsomes. Furthermore, a quantitative reduction in UDPGT partiaiiy purified from ascorbate- 
deficient guinea pigs was indicated by a marked reduction in protein banding at 55,000 daitons when 
compared to UDPGT partially purified from ascorbate-supplemented animals. 
UDP-glucuronyltransferase (UDPGT, EC 2.4.1.17) 
is quantitatively the most important detoxifying reac- 
tion in mammalian metabolism [I]. Multiple isozymes 
of UDPGT have been identified, each consisting of a 
different number of monomeric poiypeptide chains 
[2,3]. UDPGTis a tightly-bound microsomal enzyme 
and its activity is dependent on the membrane 
environment [4-7]. Factors which influence the mem- 
brane environment have been shown to alter UDPGT 
activity [4--121. With respect to diet, protein restric- 
tion [S. 91, fat deprivation [lo], cholesterol fatty liver 
[ll], and choline deficiency [12] have all been shown 
to modify properties of the microsomal membrane 
and alter UDPGT activity. A deficiency in dietary 
ascorbic acid has also been shown to result in a 
reduction in the specific activity of UDPGT towards 
~-aminophenol 1131. There was no reduction in the 
specific activity towards acetaminophen or bihrubin, 
suggesting that one isozyme may be altered in ascor- 
bate deficiency (131. This reduction in specific activity 
of UDPGT in ascorbate-deficient guinea pigs was not 
due to an alteration in the apparent affinity either for 
the substrate,p-aminophenol, or the cofactor, uridine 
S’-diphosphoglucuronic acid. 
The purpose of this study was to investigate the 
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biochemical role by which dietary ascorbic acid influ- 
ences hepatic UDPGT. Qualitative and quantitative 
studies were carried out in partially purified UDPGT 
fractions from ascorbate-supplemented and ascorb- 
ate-deficient guinea pigs using the substrate p-nitro- 
phenol. Studies examining qualitative properties of 
UDPGT included: thermal inactivation, stability of 
DEAE-cellulose fractions to storage at 4”, and puri- 
fication characteristics. Several important proper- 
ties of microsomal membranes from ascorbate-sup- 
plemented and ascorbate-deficient guinea pigs were 
also analyzed including membrane fluidity using an 
apolar core probe, 1,6-diphenyl-1,3,5_hexatriene 
(DPH), and content of phosphatidylcholine, total 
phospholipid and cholesterol. 
In addition, quantitative analysis of UDPGT pro- 
tein involving subjection of partially purified UDPGT 
from ascorbate-supplemented and ascorbate-defi- 
cient animals to sodium dodecyl sulfate-polyacryla- 
mide gel electrophoresis (SDS-PAGE) was carried 
out. 
MATERIALS AND METHODS 
~u~e~~u~~. Emulgen 911 was purchased from the 
KaoCo, (Tokyo, Japan). Triton X-100, sodium ascor- 
bate, ascorbylpalmitate, UDP-glucuronic acid, UDP- 
N-acetylglucosamine, DEAE-cellulose, DEAE- 
Sephadex, horseradish peroxidase (80 units/mg pro- 
tein), p-hydroxyphenylacetic acid, cholesterol ester- 
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ase (bovine pancrease, 650 units/g protein), 
cholesterol oxidase (Pseudomonas, 40 units/mg pro- 
tein), cholesterol (99%), L-phosphatidylcholine (egg 
yolk and bovine brain), UDP-glucuronic acid 
agarose, and DPH were purchased from the Sigma 
Chemical Co. (St Louis, MO). Sodium cholate was 
purchased from Fischer Chemicals (Fair Lawn, NJ). 
p-Nitrophenol was purchased from Eastman Kodak 
(Rochester, NY). Acrylamide and N’,N’-methylene 
bisacrylamide were purchased from International 
Biotechnologies, Inc. (New Haven, CT). Sodium 
dodecyl sulfate was purchased from BDH Chemicals 
Ltd (Poole, U.K.). Silica gel TLC plates (60 
HTLClO x 20 cm) were purchased from the What- 
man Co. (Clifton, NJ). Ascorbic acid deficient diet 
(guinea pig pelleted) was obtained from Nutritional 
Biochemicals (Cleveland, OH). Male Hartley guinea 
pigs were purchased from the Michigan Department 
of Public Health (Lansing, MI). All chemicals used 
were of reagent grade. 
Guinea&s. Guinea pigs (young adults) were kept 
on the ascorbic acid-deficient diet ad lib. for l&21 
days; one group received 2 mg ascorbate/mLof drink- 
ing water daily and the other group received no ascor- 
bic acid in their drinking water. Guinea pigs on the 
ascorbic acid-deficient regimen had minimal joint 
hemorrhages and were not frankly scorbutic. There 
were no significant differences in their rate of weight 
gain during the experimental period, compared with 
animals on the ascorbic acid-supplemented diet. The 
average weight of guinea pigs on the ascorbic acid- 
deficient diet was 360 * 25 g while the average weight 
of the ascorbic acid-supplemented guinea pigs was 
373 ? 14 g. Liver ascorbic acid content was 
31.3 t 5.7 mg/lOO g and3.7 2 1.4 mg/lOO gwet liver 
weight for the ascorbate-supplemented and -deficient 
animals respectively. 
Preparation of guinea pig tissues. Animals were 
decapitated and exsanguinated, and their livers were 
quickly removed and placed on ice. All of the fol- 
lowing procedures were carried out at 4”. Homo- 
genates (20%, w/v) were prepared in 0.1 M sodium 
phosphate, pH 7.4, with a Potter-Elvehjem glass 
homogenizer. The homogenates were centrifuged at 
12,000 gfor30 min. The 12,000 gsupernatant fraction 
was centrifuged for 60 min at 100,OOOg to harvest 
microsomes. The 12,000 g supernatant fraction and 
100,000 g microsomal pellet were stored at -20”. 
Ascorbic acid and protein determination. Ascorbic 
acid concentration was determined by the method of 
Zannoni et al. [14]. Protein was determined by the 
methodofLowryeta1. [15]with bovineserumalbumin 
as the standard. 
Cytochrome P-450. Cytochrome P-450 was deter- 
mined in the 100,OOOg microsomal pellet from the 
reduced carbon monoxide difference spectrum 
according to the method of Omura and Sato [ 161 with 
assay conditions as previously described [ 131. A molar 
extinction coefficient of 91 mM_’ cm-’ was used. 
Purification of UDP-glucuronyltransferase. The 
purification procedure was as described by Singh et 
al. [4] with modifications: Microsomes (25&300 mg 
protein/ml) in 25 mM Tris-HCI, pH 7.4, 25% gly- 
cerol, and 0.1 mM dithiothreitol (DTT) were solu- 
bilized with the addition of Emulgen 911 (0.67mg 
detergent/mg protein). After stirring for 1 hr at 4”, 
the Emulgen 911-treated microsomes were centri- 
fugedfor15 minatlOO,OOOgtoobtainthesupernatant 
fraction which contained 90% of the UDPGT activity. 
Approximately 10 mL of this fraction (15-18 mg 
protein/ml) was applied directly to a column of 
DEAE-cellulose (22 cm x 1 cm) which had been 
equilibrated previously with 25 mM Tris-HC1, pH 
7.4,25%glycerol,andO.l mMDTT.UDPGTprotein 
was not retained and was eluted in the first major pro- 
tein peak with 25 mM Tris-HCl, pH 7.4, 25% gly- 
cerol, and 0.1 mM DTT. The DEAE-cellulose eluant 
(4.0 mg protein/ml) was applied to a DEAE-Sepha- 
dex column (22 cm x 1 cm), previously equilibrated 
with 25 mM Tris-HCl, pH 7.4, 25% glycerol. and 
0.1 mM DTT. UDPGT protein was not retained on 
this column and was eluted in the first major protein 
peak with 25 mM Tris-HCI, pH 7.4, 25% glycerol, 
and0.1 mM DTT. The eluant from the DEAE-Sepha- 
dex column (1.0 to 2.0 mg protein/ml) was then 
applied to a high affinity UDP-glucuronic acid agarose 
column (6 cm x 0.5 cm) previously equilibrated with 
25 mM Tris-HCI, pH 7.4,25% glycerol, and 0.1 mM 
DTT. The column was washed with a 2-bed volume of 
25 mM Tris-HCI, pH 7.4,25% glycerol, and 0.1 mM 
DTI, and UDPGT was eluted with a 2-bed volume of 
5 mM UDP-glucuronic acid. 
p-Nitrophenol glucuronidation. The assay was as 
described by Isselbacher eta/. with modifications [ 171: 
Microsomes (2&25 mg protein/ml) were treated 
with Emulgen 911 (0.67 mg detergent/mg protein) 
with continuous stirring at 4” for 30 min to activate 
UDPGT. The reaction mixture contained: 100 mM 
sodium phosphate buffer, pH 7.1, 1 mM UDPGA. 
and0.6 mMp-nitrophenolinafinalvolumeof0.4 mL; 
incubations were carried out in lo-mL Erylenmeyer 
flasks at 37”. Aliquots (0.75 pL) were removed at 0,5, 
10, and 20 min and placed in 1.5 mL of 0.25 N KOH. 
The samples were spun at 10,OOOg for 5 min. and 
the p-nitrophenol glucuronidation was measured 
spectrophotometrically by the absorbance decrease 
at 400 nm. A molar extinction coefficient of 
1840 M-’ cm-’ was used. 
UDP-N-acetylglucosamine: specific activator. 
Assay conditions were as described above except that 
hepatic microsomes were preincubated with UDP-N- 
acetylglucosamine (2.0 mM) for 15 min, and p-nitro- 
phenol activity was assayed as described above. 
Flavin monooxygenase activity towurds dimethyl- 
aniline. Dimethylaniline metabolism was measured 
by following the oxidation of NADPH at 340 nm as 
described by Tynes and Hodgson [18] with modi- 
fications described by Brodfuehrer and Zannoni [ 191. 
The reaction rates were determined with a molar 
absorption coefficient of 6220 M-’ cm--‘. 
Preparation of L-phosphatidylcholine micelles. 
Phosphatidylcholine micelles were prepared as pre- 
viously described (131. Phosphatidylcholine [&25 pg 
P (phosphorus)/mg protein] was preincubated with 
UDPGT for 30 min on ice before assaying forp-nitro- 
phenol activity as described above. 
Measurement of total phospholipids. Total 
phospholipids were measured by the method of 
Raheja et al. [20]. Lipids were extracted from crude 
hepatic microsomes (0.3 mL of 20 mg protein/ml) 
with 4.5 mL of chloroform/methanol (2: 1). The 
extracted lipids (175 pL) were dried in a heating block 
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(60”) under a stream of nitrogen. Chloroform 
(0.4 mL) and 0.1 mL of a chromogenic solution were 
added to the dried lipid. The chromogenic solution 
reacts directly with the phospholipid phosphorus and 
a Prussian blue complex is formed which has an 
absorption maximum at 710 nm. Phosphatidylcholine 
(0 to 4.1 pg P/mg) f rom bovine brain (10 mg protein/ 
mL) was used as the standard. 
TLC spot analysis of phosphatidylcholine. The 
specific quantity of phosphatidylcholine was deter- 
mined as described by Levy et al. [21] with modi- 
fications: phosphohpids from hepatic microsomes 
were extracted with chloroform/methanol (2 : 1) 
and dried on a heating block (60”) under a stream of 
nitrogen as described above. The dried lipid was ex- 
tracted with 100 pL of chloroform/methanol (2: l), 
vortexed for 1 min, and analyzed by thin-layer 
chromatography. Samples were spotted with a 10 pL 
Hamilton syringe on a HPTLC 60 plate previously 
treated with methanol. The samples were washedwith 
30 and 20 ,uL of chloroform/methanol (2 : l), vortexed 
for 30 set, and spotted on the plates. The plates were 
chromatographed in chloroform/methanol/acetic 
acid/distilled water (100 : 30 : 35 : 3, by vol.). The sol- 
vent system separates phosphatidylethanolamine, 
phosphatidylserine, phosphatidylinositol, and phos- 
phatidylcholine with Rr values of: 0.60, 0.44, 0.33 
and 0.17 respectively. After development, the plates 
were dried and phospholipid spots were visualized by 
iodine vapor and identified by comparison to stan- 
dards (Sigma). The spots representing phosphatidyl- 
choline were scraped from the plates, extracted with 
3 mL of chloroform and methanol, and vortexed for 
1 min; then 2.7 mL of distilled Hz0 was added. The 
mixture was allowed to settle for 30 min and the bot- 
tom chloroform layer containing the phospholipid 
was removed. The quantity of phosphatidylchohne 
(phosphorus) was determined as described above. 
MembraneJIuidity. Membranefluiditywasassessed 
by the method of Kuhry et al. [22], using the apolar 
core probe. The probe was made as follows: 16 pL of 
4.5 mM DPH was added to 4 mL of 0.05 M Tris, pH 
7.4. Hepatic microsomes were diluted with either 
0.05 MTris,pH7.4,0.5 mMascorbicacid,or0.5 mM 
ascorbylpalmitate to 1.6 mg protein/ml and stirred 
in a cold room (4”) for 30 min. Samples were spun at 
10,OOOg to remove excess ascorbic acid or ascor- 
bylpalmitate and rediluted with 0.05 M Tris, pH 7.4. 
Twenty microliters of the rediluted microsomes was 
added to 2 mL of the Tris buffer containing 8.95 pL of 
theprobe,andincubatedfor60 minat37’inaDubnoff 
shaking water bath. The fluorescence intensity was 
measured with an SLM 8000 spectrophotometer 
(excitation wavelength 340 nm; emission 450 nm) 
equipped to keep the cell suspension at 37”. Four 
polarization angles were measured: 90/90,90/O, O/O, 
and O/90. A control of 20 pL of 1.6 mg/mL micro- 
somai protein in 2 mL of Tris, pH 7.4, was subtracted 
from all polarization measurements before calcu- 
lating anisotropy values. 
Cholesterol content. The quantity of cholesterol in 
hepaticmicrosomes was determined by the method of 
Heider and Boyett [23]. Hepatic microsomes (20,40, 
60 ,uL of 5 mg protein/ml) were placed in 100 pL of 
0.1 M K2HP04 and 0.25 mL of ethanol with a final 
volume of 125 pL. Standards contained &8 pg chol- 
esterol (CHO) in ethanol in 0.1 mL of K2HP04 to 
a final volume of 125 pL. Ten microliters of 80 mM 
sodium cholate in 4% Triton X-100 was added to solu- 
bilize cholesterol in the membrane. The samples stood 
at room temperature for 30 min and then 1 mL of 
enzyme mixture (19.4 mL of 0.1 M K2HP04, 0.45 mL 
of 0.2 units/ml cholesterol esterase, 2.0 units/ml 
cholesterol oxidase, 20 units/ml horseradish per- 
oxidase and 8 mg/mL p-hydroxyphenylacetic acid) 
was added. The samples were incubated at 37” for 
30 min in a shaking water bath and read on a fluoro- 
meter with an excitation of 325 nm and an emission at 
415 nm. Controls contained membranes without the 
enzyme mixture and the enzyme mixture without the 
membrane. 
Sodium dodecyl sulfate-polyacrylamide gel elec- 
trophoresis. Polyacrylamide slab gel electrophoresis 
in the presence of sodium dodecyl sulfate was per- 
formed using the discontinuous buffer system 
described by Laemmli [24]. Protein samples (l-10 pg) 
which had been treated previously with 1% SDS and 
1% mercaptoethanol at 100” for 3 min were applied to 
a 7.5% acrylamide gel and subjected to electro- 
phoresis in a vertical slab electrophoresis assembly 
(Hoefer Scientific Instruments). Electrophoresis was 
carried out at 50 mA/gel during separation. The gels 
were stained with the silver stain technique [25]. The 
standard proteins used as molecular weight markers 
were rabbit muscle phosphorylase B (92,500 daltons), 
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Fig. 1. Lineweaver-Burk plot of the effect ofp-nitrophenol 
(p-NP) on p-aminophenol (p-AP) glucuronidation in hep- 
atic microsomes isolated from ascorbate-supplemented 
guinea pigs. Similar kinetics were obtained in the ascorbate- 
deficient hepatic microsomes. p-Aminophenol glucuron- 
idation was measured in the presence (+) and the absence 
(El) of p-nitrophenol (1 mM). p-Aminophenol (1.0 to 
0.12 mM) was added to the incubation mixture and assayed 
as described under Materials and Methods with modi- 
fications: 0.5 mg/mL microsomal protein was sonicated 
using a Branson Cell Disrupter 200 (20 kHz) for 5 min on 
ice at a continuous pulse and there was no Triton X-100 in 
the incubation mixture. N = 3 and the hepatic level of 
ascorbic acid in the supplemented group was 31.3 + 5.7 mg/ 
1OOg and in the deficient 3.7 t 1.4 mg/lOOg wet liver 
weight. 
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(nmol/lOO mg protein) 
Ascorbic acid 
(mg/lOO g liver) 
Deficient diet 
plus ascorbate 2.1 r 0.27 (4) 84.8 2 10.4 (4) 31.3 -c 5.7 (4) 
Deficient diet 0.67 r 0.43* (6) 36.6 5 5.2* (6) 3.7 k 1.4* (6) 
Assay conditions for p-nitrophenol, cytochrome P-450 and ascorbic acid were as described under 
Materials and Methods. The numbers in parentheses equal the number of animals, and the data are 
means 2 SD. 
* P < 0.001. 
ovalbumin (45,000 daltons), bovine carbonic anhy- 
drase (31,000 daltons), soybean trypsin inhibitor 
(21,500 daltons), and hen eggwhite lysozyme (14,400 
daltons). 
Statistical methods. A two-tailed Student’s t-test 
was used for all of the data analysis. 
RESULTS 
Hepatic microsomes from guinea pigs fed an 
ascorbate-deficient diet had a 68% decrease in the 
specific activity of UDPGT towards the substrate, p- 
nitrophenol (Table 1). Concomitant with this 
reduction, there was a 56% decrease in the quantity 
of cytochrome P-450 which had been reported earlier 
in ascorbic acid deficient guinea pigs [26]. The 
addition of ascorbic acid (0.25 to 2.0 mM) in vitro had 
no effect on UDPGT activity towards p-nitrophenol 
in either the ascorbate-supplemented or ascorbate- 
deficient animals. 
p-Nitrophenol was found to be acompetitive inhibi- 
tor of p-aminophenol glucuronidation with a Ki of 
0.28 mM (Fig. 1). Unlike p-nitrophenol, in our pre- 
vious study, bilirubin and acetaminophen were found 
to be noncompetitive and uncompetitive inhibitors of 
p-aminophenol glucuronidation respectively [ 131. 
UDP-ZV-acetylglucosamine (UDPGLCNAC, 
2.5 mM), a specific activator of UDPGT, had no 
significant effect on the initial rate of UDPGT in the 
absence or presence of Emulgen 911 in ascorbate- 
deficient and ascorbate-supplemented animals (Table 
2). Other concentrations of UDPGLcNAC (1.0 to 
5.0 mM) were also found to have no effect on UDPGT 
activity. 
Microsomal UDPGT from ascorbate-deficient ani- 
mals in the presence of Emulgen 911 was more labile 
to thermal inactivation than UDPGT from ascorbate- 
supplemented animals (Fig. 2). At 42”, microsomal 
UDPGT from ascorbate-deficient guinea pigs lost 
41% of its activity compared to 11% in UDPGT from 
ascorbate-supplemented animals. Only 9% of 
UDPGT activity remained in the ascorbate-deficient 
animals at 52“, while the ascorbate-supplemented 
retained 31% of its original activity. 
Table 2. Effect of uridine 5’-diphospho-N-acetylglucosamine (UDPGLcNAC) on hepatic UDP- 
glucuronyltransferase in the absence and presence of Emulgen 911 
UDP-glucuronyltransferase (nmol/mg protein) 
Deficient diet 
plus ascorbate Deficient diet 
Without Emulgen 911 
-UDPGLcNAC 
5 min 9.0 + 1.5 (3) 5.5 + 1.0* (3) 
20 min 15.1 + 3.5 (3) 10.9 t 1.8 (3) 
+UDPGLcNAC (2 mM) 
5 min 10.5 2 3.0 (4) 7.0 + 1.5 (4) 
20 min 22.4 2 6.1 (4) 15.1 t 2.6 (4) 
With Emulgen 911 
-UDPGLcNAC 
5 min 12.0 “_ 0.8 (4) 6.0 + 0.6t (5) 
20 min 18.9 * 4.7 (4) 12.5 2 1.3$ (5) 
+UDPGLcNAC (2 mM) 
5 min 10.8 f 2.6 (4) 8.4 ? 2.95 (5) 
20 min 21.0 t 5.0 (4) 17.0 f 4.S (5) 
The assay is described under Materials and Methods. The numbers in parentheses equal the 
number of animals. Data are means k SD. 
* P < 0.05 vs deficient diet plus ascorbate. 
t P < 0.001 vs deficient diet plus ascorbate. 
$ P < 0.02 vs deficient diet plus ascorbate. 
I Not significant. 
Alterations in ascorbate deficiency 1089 
Fig. 2. Thermal inactivation of Emulgen 911 soluble 
UDPGT from ascorbate-supplemented and -deficient 
guinea pigs. Assay conditions were as described under 
Materials and Methods with modifications: microsomes 
treated with Emulgen 911 (0.67 mg detergent/mg protein) 
were spun for 1.5 min at 100,000 g. The supernatant fraction 
was incubated in a water bath at each temperature for 
1 min, and then placed on ice for 1 min before being assayed 
for p-nitrophenol activity. The hepatic level of ascorbic 
acid in the supplemented group (B) was 31.3 C 5.7 mg/ 
100 g and in the deficient (H) 3.7 + 1.4 mg/lOO g wet liver 
weight. Data are means 2 SD, N = 4. Key: * P < 0.01, 
** P < 0.02. and *** P < 0.001. 
Qualitative differences were also apparent during 
the purification of UDPGT. While both groups of 
animals lost considerable UDPGT activity during 
the purification procedure. UDPGT activity from 
ascorbate-deficient guinea pigs eluted from the 
high-affinity UDP-glucuronic acid agarose column 
chromatography was often undetectable (Table 3). 
The in vitro addition of ascorbic acid (0.25 to 2.0 mM) 
or phosphatidylcholine [6 to 25 pg P (phosphorus)/ 
mg protein] could not stabilize UDPGT activity from 
the ascorbate-deficient animals. In addition, ascor- 
bate-deficient guinea pig UDPGT eluted from a 
Fig. 3. Effect of phosphatidylcholine on UDPGT activity 
eluted from a DEAE-cellulose column. UDPGT from hep- 
atic microsomes was partially purified, and p-nitrophenol 
activity was assayed as described in Materials and Methods. 
DEAE-cellulose eluant from both ascorbate-supplemented 
(m) and ascorbate-deficient (a) guinea pig livers was stored 
on ice at 4” for 4 days and reassayed for activity towards p- 
nitrophenol in the presence and absence of phospha- 
tidylcholine (&25 pg P/mg protein). The data are means 
(-+SD) of two experiments; the hepatic levels of ascorbic 
acid were 31 k 8 mg/lOO gin the supplemented animals and 
1.6 2 1.3 mg/lOOg wet liver weight in tie deficient. Key: 
* P < 0.05, and ** P < 0.02. 
DEAE-cellulose column and stored for 4days on 
ice at 4” lost over 50% of its activity whereas the 
ascorbate-supplemented lost only 10% (Fig. 3). 
However, when phosphatidylcholine (6.2 to 12.5 pg 
P/mg protein) was added to ascorbate-deficient 
UDPGT fractions which had lost activity upon 
storage, the level of activity was reconstituted but 
never approached that found in the ascorbate-sup- 
plemented fractions (Fig. 3). Higher concentrations 
of phosphatidylcholine (25-100 pg P/mg protein) had 
Table 3. Purification of hepatic microsomal UDPGT from ascorbate-supplemented and ascorbate-deficient guinea pigs 
Fraction 
Total activity 











31 76 0.4 
80 76 1.1 
21 12 1.8 
8 3 2.7 
7 0.7 10 
Ascorbic acid-deficient 
microsomes 






34 7.5 0.5 
34 75 0.5 
10 11 0.9 
4 4 1.0 
0.7 0.6 1.2 
The purification procedure was carried out as described under Materials and Methods. The data represent the average 
of 4 fractionations for each animal group. 
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4.4 -+ 0.3 (12) 4.7 + 0.3 (4) 4.2 + 0.3 (4) 
5.1 -t-0.4* (13) 5.1 + 0.6 (4) 4.1 + 0.4 (4) 
The assay for membrane fluidity is described under Materials and Methods. The numbers 
in parentheses equal the number of animals and the data are means + SD. AA = ascorbic 
acid; AP = ascorbylpalmitate. 
* P < 0.001. 
Table 5. Cholesterol, total phospholipid, and phosphatidylcholine content of hepatic microsomes 
from ascorbate-supplemented and ascorbate-deficient guinea pigs 
Treatment Cholesterol 
(,umol/mg protein) 
Total phospholipid Phosphatidylcholine 
(pm01 P/100 mg protein) 
Deficient diet 
plus ascorbate 0.034 f 0.007 (4) 109.3 r+_ 7.4 (3) 17.2 + 5.2 (3) 
Deficient diet 0.029 r 0.003* (6) 116.1 + 7.1* (3) 16.‘) + 4.0* (3) 
Assay conditions are described under Materials and Methods. The numbers in parenthesea equal 
the number of animals, and the data are means 2 SD. 
* Not significant 
no effect on UDPGT activity or were slightly inhibi- 
tory. 
Microsomes from ascorbate-deficient guinea pigs 
had a statistically significant increase of 14% in mem- 
brane fluidity (Table 4). This could not be reversed 
with the in vitro addition of ascorbic acid. However, 
ascorbylpalmitate, a more lipophilic form of the vit- 
amin, could reverse the increase in membrane fluidity 
found in microsomes from ascorbate-deficient 
animals. Palmitic acid had no effect on membrane 
fluidity. Furthermore, there were no differences in the 
quantity of cholesterol, total phospholipid, or phos- 
phatidylcholine of hepatic microsomes from the 
ascorbate-supplemented and ascorbate-deficient 
guinea pigs (Table 5). 
UDPGT partially purified from ascorbate-deficient 
and ascorbate-supplemented guinea pigs was sub- 
jected to SDS-PAGE to determine if quantitative dif- 
ferences existed in the respective enzymes. There was 
a consistent decrease in banding in the 55,000 dalton 
region with the ascorbic acid deficient guinea pig 
UDPGT compared to the ascorbate-supplemented 
(Fig. 4). Previous studies indicated that the guinea pig 
UDPGT isozyme with activity towardsp-nitrophenol 
had a molecular weight of 55,000 daltons when sub- 
jected to SDS-PAGE [4]. Furthermore, there was no 
detectable flavin-containing monooxygenase activity 
towards dimethylaniline or cytochrome P-450 as 
determined by the reduced carbon monoxide binding 
spectrum in UDPGT fractions eluted from the high- 
affinity’UDP-glucuronic acid agarose column. 
DISCUSSION 
Previous studies showed a reduction in specific 
activitytowardsp-aminophenolwhereasbilirubinand 
acetaminophen glucuronidation were unaffected, 
suggesting that one isozyme of UDPGT is altered in 
ascorbate deficiency [ 131. In the present study, the 
glucuronidation of another planar phenol, p-nitro- 
phenol, was also jeopardized in ascorbate deficiency. 
Burchell [27] found that activities towards 2-amino- 
phenol and 4-nitrophenol copurified, maintaining 
approximately the same ratio of specific activities over 
five purification steps. In keeping with this, the 
present study foundp-nitrophenol to be a competitive 
inhibitor of p-aminophenol glucuronidation. In con- 
trast, previous studies showed that acetaminophen 
and bilirubin were uncompetitive and noncompetitive 
inhibitors ofp-aminophenol glucuronidation respect- 
ively [ 131. The selective effect of the vitamin on hep- 
atic glucuronidation is in keeping with the findings 
that only certain isozymes of cytochrome P-450 are 
jeopardized in ascorbate deficiency [26]. 
As a possible mechanism to explain the reduction 
in UDPGT activity in ascorbate deficiency, the effect 
of UDP-N-acetylglucosamine (UDPGLcNAC) was 
examined. UDPGLcNAC is a specific activator of 
UDPGT which does not perturb the membrane and 
may allosterically affect the UDP-glucuronyltransfer- 
ase [28] or assist the transport of the cofactor. 
UDPGA, through an impermeable phospholipid bar- 
rier [29]. In previous studies, UDPGLcNAC acti- 
vated UDP-glucuronyltransferase in the guinea pig 
towards many substrates including p-nitrophenol 
[30]. In contrast, the present study indicated that 
UDPGLcNAC had no effect on the initial rate of 
UDPGT in either the ascorbate-supplemented or 
ascorbate-deficient animals (Table 2). A possible 
explanation is that UDPGLcNAC, like other sulfhy- 
dry1 agents, may maintain a linear enzymatic rate. 
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Fig. 4. SDS-electrophoresis of partially purified hepatic UDPGT from ascorbate-supplemented and 
-deficient guinea pigs (N = 4). Electrophoresis was performed in 7.5% polyacrylamide gel as described 
in Materials and Methods. The direction of migration was from top to bottom. Protein was loaded as 
follows: (left lo right) lane 1. ascorbic acid supplemented, ~,LQ; lane 2, ascorbic acid deficient, 8pg; 
lane 3, protein standards, 5 pg; lane 4, ascorbate-supplemented, 6 pg; and lane 5 ascorbate-deficient, 
6 pg. The hepatic level of ascorbic acid in the supplemented group was 31.3 + 5.7 mg/lOO g while the 
deficient was 3.7 + 1.4 mg/lOOg wet liver weight. The standard proteins used as molecular weight 
markers were rabbit muscle phosphorylase B (92,500 daltons); bovine serum albumin (66,200 daltons); 
hen eggwhite ovalbumin (45,000 daltons); bovine carbonic anhydrase (31,000 daltons); soybean trypsin 
inhibitor (21.500 daltons); and hen eggwhite lysozyme (14,400 daltons). 
Past studies often assayed UDPGT activity at 30 or 
60 min, and the reported activation by UDPGLcNAC 
may be due to prolongation of the enzymatic rate of 
the reaction [2&30]. 
Evidence has been provided indicating that both 
qualitative and quantitative alterations occur in 
microsomal and partially purified UDPGT from 
ascorbate-deficient guinea pigs. Qualitative changes 
found in UDPGT from ascorbate-deficient animals 
included an increased lability to thermal inactivation, 
storage of DEAE-cellulose fractions at 4”. purifi- 
cation with UDP-glucuronic acid agarose column 
chromatography, and increased microsomal mem- 
brane fluidity. Qualitative differences have also been 
reported in other enzymes jeopardized in ascorbate 
deficiency. The flavin-containing monooxygenase 
partially purified from ascorbate-deficient guinea pigs 
is more dependent on the addition of exogenous FAD 
for optimal activity, has enhanced susceptibility to 
substrate inhibition, and is more labile upon freezing 
[19]. In addition, cytochrome P-450, another micro- 
somal enzyme jeopardized in deficiency, had alter- 
ations in both type I and type II substrate binding 
spectra in ascorbate-deficient guinea pigs [31,32]. It 
should be noted, however, that qualitative alterations 
found in ascorbate-deficient animals are relatively 
specific since other microsomal electron transport 
components such as cytochrome b5 and cytochrome 
b5 reductase are not affected [33]. 
These qualitative alterations may be due to subtle 
conformational changes in the secondary or tertiary 
structure of UDPGT in ascorbate-deficient animals 
resulting in a catalytically impaired enzyme. One 
possible explanation is that the increase in membrane 
fluidity in ascorbate deficiency may change important 
hydrophobic interactions between membrane phos- 
pholipids and UDPGT, resulting in a structurally 
unstable enzyme or enzyme complex. Both excessive 
increases or decreases in membrane fluidity have been 
shown to be deleterious to UDPGT activity [34]. 
UDPGT may be sensitive to changes in protein-lipid 
interactions because it is an oligomer whose activity is 
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dependent on the proper association of monomeric 
polypeptides [2,3]. Thus, alterations in the mem- 
brane environment may result in the disaggregation 
of these important components of UDPGT resulting 
in a reduction in catalytic activity. The use of a more 
specific fluorescent probe which binds directly to 
UDPGTwould help determine whether phospholipid 
membrane environment immediately surrounding 
UDPGT is also altered. Furthermore, the fact that 
ascorbylpalmitate could restore membrane fluidity in 
the ascorbate-deficient animals suggests a role for the 
vitamin in maintaining the integrity of the phospho- 
lipid environment. A possible explanation is that the 
lipophilic form of the vitamin is an effective carrier of 
ascorbic acid across the lipoid-microsomal mem- 
brane, thus allowing the vitamin to associate with 
membrane phospholipids. These findings are in keep- 
ing with previous studies which showed that only the 
lipophilic form of ascorbic acid could reverse alter- 
ations found in the type II aniline-cytochrome P-450 
binding spectra in ascorbic acid deficient guinea pigs 
[321. 
In addition to these qualitative differences, there 
was a quantitative loss of UDPGT protein at 55,000 
daltons in ascorbate deficiency when partially purified 
fractions subjected to SDS-PAGE were compared to 
the ascorbate-supplemented. In keeping with this, 
both the flavin-containing monooxygenase [19] and 
cytochrome P-450 [26] were found to be quantitatively 
reduced in ascorbate-deficient animals. This quanti- 
tative loss of the cytochrome P-450 [26] and the flavin- 
containing monooxygenase [19] of the protein was 
not due to an alteration in protein synthesis, since 
ascorbate-deficient guinea pigs were shown to have 
the same fold induction with phenobarbitol 
treatment. However, since UDP-glucuronyltransfer- 
ase is regulated by a different operon than cytochrome 
P-450 [35], a reduction in protein synthesis cannot be 
ruled out at the present time. It seems unlikely that 
excessive oxidation of membrane lipids is responsible 
for the quantitative loss of UDPGT protein since lipid 
peroxidation was found to be 30% higher in the 
ascorbate-supplemented animals compared to the 
ascorbate-deficient animals [36]. In addition, 
enhanced release of degradative enzymes from lyso- 
somes also seems unlikely to explain this quantitative 
loss in UDPGT protein since this degradative effect 
would be non-specific resulting in a quantitative loss 
of all proteins in the microsomal membrane. In ascor- 
bate deficiency, there is a selective loss of certain iso- 
zymes of specific proteins like cytochrome P-450 [26]. 
The role of dietary ascorbic acid is complex and 
multifactorial in that it protects against both quali- 
tative alterations in UDPGT structure and a quanti- 
tative loss of the enzyme protein. A cascade of 
deleterious alterations may occur in ascorbate-defi- 
cient animals in which qualitative or conformational 
alterations in UDPGT structure make the enzyme 
more vulnerable to inactivation and degradation. 
Because UDPGTis quantitatively the most important 
detoxifying enzyme in mammalian metabolism, 
understanding factors such as dietary ascorbate which 
influence its activity is important because decreases 
could result in enhanced toxicity of environmental 
chemicals, pharmaceutical agents, or endogenous 
compounds. 
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